Prognostic’s Factors of Head and Neck Paragangliomas Evolution
Learn more about:
Related Access Program
Children’s Hospital of Philadelphia – Paraganglioma
British Columbia Cancer Agency – Paraganglioma
Molecular Insight Pharmaceuticals, Inc. – Paraganglioma
Jubilant DraxImage Inc. – Paraganglioma
Children’s Hospital Medical Center, Cincinnati – Paraganglioma
University of California, San Francisco – Paraganglioma
Related Clinical Trial
Exendin PET/CT for Imaging of Paragangliomas
Prognostic’s Factors of Head and Neck Paragangliomas Evolution
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
GA-68 DOTA-TOC of Somatostatin Positive Malignancies
Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors